ENvue Medical Stockholders Approve Reverse Stock Split to Regain Nasdaq Compliance
FEED sits 43% above its 52-week low of $0.29.
Summary
ENvue Medical stockholders approved a reverse stock split proposal, authorizing the board to implement a split between 1-for-2 and 1-for-50 within one year to address Nasdaq's minimum bid price deficiency.
Key Events · Corporate Governance and Compliance · FEED
-
Reverse Stock Split Approved
Stockholders approved a reverse split at a ratio between 1-for-2 and 1-for-50, with the board authorized to determine the exact ratio and timing within one year.
-
Vote Counts
Reverse split proposal received 3,847,974 votes for, 1,062,981 against, and 19,288 abstentions. Adjournment proposal received 4,199,681 for, 594,319 against, and 136,243 abstentions.
-
Nasdaq Compliance Effort
The reverse split is intended to raise the stock price above Nasdaq's $1 minimum bid requirement, following the delisting notice received on July 10, 2026.
-
Board Discretion
The board may implement the split at any time before August 14, 2027, and will announce the chosen ratio publicly.
Analysis · FEED · Industrial Applications And Services
Stockholders approved a reverse stock split at a ratio between 1-for-2 and 1-for-50, giving the board discretion to implement it within one year. This is a critical step toward regaining Nasdaq's $1 minimum bid requirement after the delisting notice received on July 10, 2026. The board now has the tool to reduce the share count and boost the stock price, but the exact ratio and timing remain undecided.
At the time of this filing, FEED was trading at $0.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.6M. The 52-week trading range was $0.29 to $17.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.